Emerging drugs for treating skeletal muscle injury and promoting muscle repair

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.1, 2011-03, pp. : 163-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidelines for Models of Skeletal Muscle Injury and Therapeutic Assessment

Cells Tissues Organs, Vol. 202, Iss. 3-4, 2016-11 ,pp. : 214-226

Karger

Access to resources Recommend Favorite

Emerging drugs for sarcopenia: age-related muscle wasting

By Lynch Gordon S

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite

Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury

By Sardo Vilma A Pereira Sandro L Oliveira Paulo J

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 129-146

Informa Healthcare

Access to resources Recommend Favorite

The Effect of Melatonin on Plasma Oxidant–Antioxidant Skeletal Muscle Reperfusion Injury in Rats

By Halici M Narin F Turk CY Saraymen R Baykan A Kabak S

The Journal of International Medical Research, Vol. 32, Iss. 5, 2004-09 ,pp. : 500-506

Field House Publishing

Access to resources Recommend Favorite

Update on emerging drugs for sarcopenia – age-related muscle wasting

By Lynch Gordon S

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite